de Fijter JW et al. |
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial. |
2017 |
Am. J. Transplant. |
pmid:28027625
|
Kabat-Koperska J et al. |
Birth defects in juvenile Wistar rats after exposure to immunosuppressive drugs during pregnancy. |
2017 |
Histol. Histopathol. |
pmid:27097725
|
Liu C et al. |
Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone. |
2017 |
Pediatr. Neurol. |
pmid:29074055
|
Cheung AY et al. |
Probable Donor-Derived Cytomegalovirus Disease After Keratolimbal Allograft Transplantation. |
2017 |
Cornea |
pmid:28614157
|
Weir MR et al. |
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. |
2017 |
Transplantation |
pmid:26950714
|
Li Y et al. |
[Study on the Effect of Immunosuppressive Agent FK506 on Growth and Migration of Lung Cancer Cell]. |
2017 |
Zhongguo Fei Ai Za Zhi |
pmid:28738959
|
Nakamura Y et al. |
Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation. |
2017 |
Intern. Med. |
pmid:28502936
|
Jouve T et al. |
New formulations of tacrolimus and prevention of acute and chronic rejections in adult kidney-transplant recipients. |
2017 |
Expert Opin Drug Saf |
pmid:28494654
|
Sanghavi K et al. |
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. |
2017 |
Pharmacogenomics J. |
pmid:26667830
|
Gardenier JC et al. |
Topical tacrolimus for the treatment of secondary lymphedema. |
2017 |
Nat Commun |
pmid:28186091
|
Kizilbash SJ et al. |
Infection rates in tacrolimus versus cyclosporine-treated pediatric kidney transplant recipients on a rapid discontinuation of prednisone protocol: 1-year analysis. |
2017 |
Pediatr Transplant |
pmid:28371243
|
Ikeda K et al. |
Intestinal perforation due to hemorrhagic Cytomegalovirus enteritis in a patient with severe uncontrolled lupus nephritis: a case and review of the literature. |
2017 |
Rheumatol. Int. |
pmid:28283734
|
Shimizu S et al. |
Reduction of FR900525 using an S-(2-aminoethyl) l-cysteine-resistant mutant. |
2017 |
J. Biosci. Bioeng. |
pmid:28185832
|
Piotti G et al. |
Once-daily prolonged-release tacrolimus formulations for kidney transplantation: what the nephrologist needs to know. |
2017 |
J. Nephrol. |
pmid:27206763
|
Ma TK et al. |
Therapeutic drug monitoring of once-daily tacrolimus (Advagraf) in a gastrectomized kidney transplant recipient. |
2017 |
Nephrology (Carlton) |
pmid:28064453
|
Percy C et al. |
Impact of Acute Infection Requiring Hospitalization on Tacrolimus Blood Levels in Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:29149962
|
Obaidat RM et al. |
Using Supercritical Fluid Technology (SFT) in Preparation of Tacrolimus Solid Dispersions. |
2017 |
AAPS PharmSciTech |
pmid:27116202
|
de Menezes AF et al. |
Pharmacologic Treatment of Vitiligo in Children and Adolescents: A Systematic Review. |
2017 |
Pediatr Dermatol |
pmid:27878842
|
Ganschow R et al. |
Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study. |
2017 |
Pediatr Transplant |
pmid:28714558
|
Tsunashima D et al. |
Development of extended-release solid dispersion granules of tacrolimus: evaluation of release mechanism and human oral bioavailability. |
2017 |
J. Pharm. Pharmacol. |
pmid:28872687
|